Jon Alexander Schwartz
Hoofd Techniek/Wetenschap/O&O bij Nanospectra Biosciences, Inc.
Profiel
Jon Alexander Schwartz is currently the Director-Clinical Research at Nanospectra Biosciences, Inc. He has an undergraduate and graduate degree from Rice University and a doctorate from the University of Texas Graduate School of Biomedical Sciences.
Actieve functies van Jon Alexander Schwartz
Bedrijven | Functie | Begin |
---|---|---|
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Hoofd Techniek/Wetenschap/O&O | 13-06-2013 |
Opleiding van Jon Alexander Schwartz
Rice University | Graduate Degree |
University of Texas Graduate School of Biomedical Sciences | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |